These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24861265)

  • 1. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
    Africander DJ; Storbeck KH; Hapgood JP
    J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy.
    Africander D; Louw R; Hapgood JP
    Biochem Biophys Res Commun; 2013 Apr; 433(3):305-10. PubMed ID: 23473756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract.
    Africander D; Louw R; Verhoog N; Noeth D; Hapgood JP
    Contraception; 2011 Oct; 84(4):423-35. PubMed ID: 21920200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic progestins used in HRT have different glucocorticoid agonist properties.
    Koubovec D; Ronacher K; Stubsrud E; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2005 Oct; 242(1-2):23-32. PubMed ID: 16125839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo.
    Ochnik AM; Moore NL; Jankovic-Karasoulos T; Bianco-Miotto T; Ryan NK; Thomas MR; Birrell SN; Butler LM; Tilley WD; Hickey TE
    Menopause; 2014 Jan; 21(1):79-88. PubMed ID: 23715406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
    Buchanan G; Birrell SN; Peters AA; Bianco-Miotto T; Ramsay K; Cops EJ; Yang M; Harris JM; Simila HA; Moore NL; Bentel JM; Ricciardelli C; Horsfall DJ; Butler LM; Tilley WD
    Cancer Res; 2005 Sep; 65(18):8487-96. PubMed ID: 16166329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis.
    Hapgood JP; Ray RM; Govender Y; Avenant C; Tomasicchio M
    Am J Reprod Immunol; 2014 Jun; 71(6):505-12. PubMed ID: 24547700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and structural basis of androgen receptor responses to dihydrotestosterone, medroxyprogesterone acetate and Δ(4)-tibolone.
    Bianco-Miotto T; Trotta AP; Need EF; Lee AM; Ochnik AM; Giorgio L; Leach DA; Swinstead EE; O'Loughlin MA; Newman MR; Birrell SN; Butler LM; Harris JM; Buchanan G
    Mol Cell Endocrinol; 2014 Feb; 382(2):899-908. PubMed ID: 24239616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.
    Ghatge RP; Jacobsen BM; Schittone SA; Horwitz KB
    Breast Cancer Res; 2005; 7(6):R1036-50. PubMed ID: 16457685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins.
    García-Becerra R; Cooney AJ; Borja-Cacho E; Lemus AE; Pérez-Palacios G; Larrea F
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):21-7. PubMed ID: 15261304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
    Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.
    Govender Y; Avenant C; Verhoog NJ; Ray RM; Grantham NJ; Africander D; Hapgood JP
    PLoS One; 2014; 9(5):e96497. PubMed ID: 24840644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.
    Louw-du Toit R; Perkins MS; Hapgood JP; Africander D
    Biochem Biophys Res Commun; 2017 Sep; 491(1):140-146. PubMed ID: 28711501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
    Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
    J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.
    Tomasicchio M; Avenant C; Du Toit A; Ray RM; Hapgood JP
    PLoS One; 2013; 8(5):e62895. PubMed ID: 23658782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
    Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
    Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity.
    Moore NL; Buchanan G; Harris JM; Selth LA; Bianco-Miotto T; Hanson AR; Birrell SN; Butler LM; Hickey TE; Tilley WD
    Endocr Relat Cancer; 2012 Aug; 19(4):599-613. PubMed ID: 22719059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
    Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H; Rakov V; Mueck AO
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.